-
June 3, 2022 Psychedelic Business Spotlight – June 3This week in psychedelic business news: Cybin moves towards clinical trials; Braxia releases data on...
-
June 3, 2022 Does MDMA Reduce Fear? New Study Has Implications for PTSD TreatmentUsing a measurement tool called the SCR, researchers found that combining MDMA with fear extinction...
-
May 31, 2022 British Columbia to Decriminalize Possession of Most DrugsThose caught with under 2.5 grams of illicit drugs, including heroin and fentanyl, will not...
-
May 27, 2022 5 Next-Generation Psychedelics Entering Clinical Trials This YearModernized psychedelic medicine is coming, whether you like it or not, so here are five...
-
May 26, 2022 How to Microdose Psilocybin According to Paul Stamets: The Stamets StackFamed mycologist Paul Stamets recommends the Stamets Stack when microdosing psilocybin. Here's how he plans...
-
May 25, 2022 Psychedelic Medicine Has Institutional Buy-In & 4 More Catalyst Summit TakeawaysAfter leaving the Catalyst Summit, I am more confident than ever in the governmental and...
-
May 21, 2022 Senator’s Wife Secretly Gave Him Psilocybin to Alleviate DepressionSenator Larry Campbell, who struggles with depression, PTSD, and “getting old," reveals that psilocybin microdoses...
-
May 19, 2022 Psychedelic Capitalism Takes a Trip to DavosFrom May 21-26, for the first time, the Davos Forum will feature The House of...
-
May 17, 2022 Comparing MindMed, Atai Life Sciences, Compass Pathways: A Psychedelic Stock AnalysisOur resident psychedelic investor explains a handful of important metrics to study when analyzing and...
-
May 16, 2022 A Brief History of MDMA: From the CIA to Raves to Psychedelic TherapyThe history of MDMA is fascinating, and it is still being written.
